Research Article
Predicting Axillary Response in Hormone Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy Using Real-World Data
Figure 2
(a) The AUC in the test set for the risk score based on the ROC curves, . (b) The AUC of the validation set for the risk score based on the ROC curves, . (c) Overall survival according to the pN stage after neoadjuvant chemotherapy (NAC), P = 0.046. (d) Disease free survival to pN stage after NAC, P = 0.041.
(a) |
(b) |
(c) |
(d) |